We here show that the epigenetic reader BRD4 and its downstream effector MYC are expressed in CML cells, including LSC, and that both targets mediate cell growth and LSC resistance in CML cells. Here, BRD4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.